Diabetes

>

Latest News

Dual GCG/GLP-1 Agonist Mazdutide 9 mg Produces 20% Weight Loss in Phase 3 Trial of Chinese Adults with Obesity / image courtesy of Courtesy of Peking University Health Science Center
Dual GCG/GLP-1 Agonist Mazdutide 9 mg Produces 20% Weight Loss in Phase 3 Trial of Chinese Adults with Obesity

November 20th 2025

GLORY-2 participants showed continuous weight loss through 60 weeks with no plateau; mazdutide also improved multiple cardiometabolic markers.

FDA Clears First CGM-Integrated Basal Insulin Dosing Optimizer for Adults With Type 2 Diabetes / Image credit: ©Araki Ilustrations/AdobeStock
FDA Clears First CGM-Integrated Basal Insulin Dosing Optimizer for Adults With Type 2 Diabetes

November 19th 2025

Preventive Health Inventory Boosts Diabetes and Hypertension Management Without Increasing Hospitalizations Among Veterans: New Study / Image credit: ©daniel0/AdobeStock
Preventive Health Inventory Boosts Diabetes and Hypertension Management Without Increasing Hospitalizations Among Veterans: New Study

November 18th 2025

Workplace Diabetes Support Checklist for Clinicians / image credit ©kenishirotie/stock.adobe.com
Diabetes Self-Management at Work: A Checklist for Clinicians

November 7th 2025

The Hidden Toll of Diabetes in the Workplace: Global Survey Data  / image credit ©Yuri/stock.adobe.com
The Hidden Toll of Diabetes in the Workplace: Global Survey Data

November 5th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.